The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Developing A Resource for Exploring the Molecular Markers of Parkinson’s Disease
Study Rationale: Our understanding of the genetic, immunological and molecular determinants of Parkinson’s disease (PD) has advanced significantly over the past decade. Using this extensive body of...
-
Research Grant, 2024Generation of Induced Pluripotent Stem Cells with Indigenous Ancestry to Promote Inclusion of North America’s First Peoples in Parkinson’s Disease Research
Study Rationale: North America’s Indigenous people with Parkinson’s disease (PD) are largely underrepresented in research studies, and biological material from these populations is rarely available to...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Discovery of Translational Pharmacodynamic Biomarkers and Biomarkers of Endo-lysosomal Pathway Pathology by Biased & Unbiased Lipidomics and Metabolomics
Study Rationale: The endolysosomal system within living cells is comprised of small, specialized structures that contain enzymes that degrade proteins and remove waste materials from the cell. Their...
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2024Preclinical Testing of Novel DBS Protocol for Long-Lasting Therapeutic Effects
Study Rationale: Deep brain stimulation is an effective therapy for motor symptoms of late-stage Parkinson’s disease. It works like a pacemaker to interrupt abnormal patterns of brain activity that...
-
Research Grant, 2024Developing Outcome Measures for Assessing Freezing of Gait: A Multi-Center Study
Study Rationale: Standardized and accurate assessment of freezing of gait (FOG), a debilitating symptom of Parkinson’s disease (PD), is needed to develop and rigorously test novel therapies. However...
-
Therapeutic Pipeline Program, 2024Photoreceptor-directed Light Therapy in Parkinson’s Disease
Study Rationale: Non-motor symptoms including sleep disturbances are common and enormously impact on the quality of life in people with Parkinson’s disease. Sleep disruption affects motor function and...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.